nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCC1—Mitoxantrone—lymphatic system cancer	0.179	0.207	CbGbCtD
Amprenavir—ABCC1—Vincristine—lymphatic system cancer	0.123	0.142	CbGbCtD
Amprenavir—CYP3A5—Teniposide—lymphatic system cancer	0.0949	0.109	CbGbCtD
Amprenavir—CYP2C19—Teniposide—lymphatic system cancer	0.0765	0.0883	CbGbCtD
Amprenavir—ABCC1—Methotrexate—lymphatic system cancer	0.0746	0.0861	CbGbCtD
Amprenavir—CYP2C9—Teniposide—lymphatic system cancer	0.0636	0.0734	CbGbCtD
Amprenavir—CYP3A5—Vincristine—lymphatic system cancer	0.0457	0.0527	CbGbCtD
Amprenavir—ABCB1—Mitoxantrone—lymphatic system cancer	0.0432	0.0498	CbGbCtD
Amprenavir—CYP3A4—Cytarabine—lymphatic system cancer	0.0376	0.0433	CbGbCtD
Amprenavir—CYP3A4—Teniposide—lymphatic system cancer	0.037	0.0427	CbGbCtD
Amprenavir—ABCB1—Vincristine—lymphatic system cancer	0.0297	0.0343	CbGbCtD
Amprenavir—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0259	0.0299	CbGbCtD
Amprenavir—ABCB1—Methotrexate—lymphatic system cancer	0.018	0.0208	CbGbCtD
Amprenavir—CYP3A4—Vincristine—lymphatic system cancer	0.0178	0.0205	CbGbCtD
Amprenavir—Affective disorder—Mitoxantrone—lymphatic system cancer	0.0118	0.088	CcSEcCtD
Amprenavir—Opportunistic infection—Fludarabine—lymphatic system cancer	0.00615	0.046	CcSEcCtD
Amprenavir—Transaminases increased—Carmustine—lymphatic system cancer	0.00261	0.0195	CcSEcCtD
Amprenavir—Depression—Mechlorethamine—lymphatic system cancer	0.00213	0.016	CcSEcCtD
Amprenavir—Sleep disorder—Fludarabine—lymphatic system cancer	0.00208	0.0155	CcSEcCtD
Amprenavir—Liver function test abnormal—Teniposide—lymphatic system cancer	0.00189	0.0141	CcSEcCtD
Amprenavir—Opportunistic infection—Methotrexate—lymphatic system cancer	0.00182	0.0136	CcSEcCtD
Amprenavir—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00182	0.0136	CcSEcCtD
Amprenavir—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.00166	0.0124	CcSEcCtD
Amprenavir—Neutropenia—Teniposide—lymphatic system cancer	0.00165	0.0124	CcSEcCtD
Amprenavir—Neutropenia—Fludarabine—lymphatic system cancer	0.00145	0.0109	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00141	0.0106	CcSEcCtD
Amprenavir—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.0014	0.0105	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00137	0.0103	CcSEcCtD
Amprenavir—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00137	0.0102	CcSEcCtD
Amprenavir—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00136	0.0102	CcSEcCtD
Amprenavir—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00133	0.00992	CcSEcCtD
Amprenavir—Diabetes mellitus—Carmustine—lymphatic system cancer	0.00132	0.0099	CcSEcCtD
Amprenavir—Anorexia—Mechlorethamine—lymphatic system cancer	0.0013	0.00973	CcSEcCtD
Amprenavir—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00119	0.00887	CcSEcCtD
Amprenavir—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00118	0.0088	CcSEcCtD
Amprenavir—Malnutrition—Fludarabine—lymphatic system cancer	0.00108	0.00811	CcSEcCtD
Amprenavir—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00106	0.00795	CcSEcCtD
Amprenavir—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.001	0.0075	CcSEcCtD
Amprenavir—Myocardial infarction—Bleomycin—lymphatic system cancer	0.000996	0.00745	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00099	0.0074	CcSEcCtD
Amprenavir—Pruritus—Mechlorethamine—lymphatic system cancer	0.000965	0.00722	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.000964	0.00721	CcSEcCtD
Amprenavir—Anorexia—Teniposide—lymphatic system cancer	0.000959	0.00717	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.000944	0.00706	CcSEcCtD
Amprenavir—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000934	0.00699	CcSEcCtD
Amprenavir—Neutropenia—Carmustine—lymphatic system cancer	0.00093	0.00696	CcSEcCtD
Amprenavir—Myalgia—Fludarabine—lymphatic system cancer	0.000922	0.0069	CcSEcCtD
Amprenavir—Discomfort—Fludarabine—lymphatic system cancer	0.000911	0.00682	CcSEcCtD
Amprenavir—Hyperglycaemia—Carmustine—lymphatic system cancer	0.000898	0.00672	CcSEcCtD
Amprenavir—Neutropenia—Vincristine—lymphatic system cancer	0.000888	0.00665	CcSEcCtD
Amprenavir—Depression—Carmustine—lymphatic system cancer	0.000885	0.00662	CcSEcCtD
Amprenavir—Decreased appetite—Teniposide—lymphatic system cancer	0.000875	0.00654	CcSEcCtD
Amprenavir—Vomiting—Mechlorethamine—lymphatic system cancer	0.000868	0.00649	CcSEcCtD
Amprenavir—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000867	0.00649	CcSEcCtD
Amprenavir—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000865	0.00647	CcSEcCtD
Amprenavir—Rash—Mechlorethamine—lymphatic system cancer	0.00086	0.00644	CcSEcCtD
Amprenavir—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00086	0.00643	CcSEcCtD
Amprenavir—Depression—Vincristine—lymphatic system cancer	0.000845	0.00632	CcSEcCtD
Amprenavir—Anorexia—Fludarabine—lymphatic system cancer	0.000843	0.00631	CcSEcCtD
Amprenavir—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.000835	0.00625	CcSEcCtD
Amprenavir—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.000834	0.00624	CcSEcCtD
Amprenavir—Myocardial infarction—Vincristine—lymphatic system cancer	0.00083	0.00621	CcSEcCtD
Amprenavir—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000823	0.00615	CcSEcCtD
Amprenavir—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000813	0.00608	CcSEcCtD
Amprenavir—Nausea—Mechlorethamine—lymphatic system cancer	0.000811	0.00606	CcSEcCtD
Amprenavir—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000809	0.00605	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Methotrexate—lymphatic system cancer	0.000808	0.00604	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000806	0.00603	CcSEcCtD
Amprenavir—Abdominal pain—Teniposide—lymphatic system cancer	0.000795	0.00595	CcSEcCtD
Amprenavir—Paraesthesia—Fludarabine—lymphatic system cancer	0.000794	0.00594	CcSEcCtD
Amprenavir—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000783	0.00586	CcSEcCtD
Amprenavir—Decreased appetite—Fludarabine—lymphatic system cancer	0.000769	0.00575	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000763	0.00571	CcSEcCtD
Amprenavir—Fatigue—Fludarabine—lymphatic system cancer	0.000762	0.0057	CcSEcCtD
Amprenavir—Inflammation—Methotrexate—lymphatic system cancer	0.000757	0.00567	CcSEcCtD
Amprenavir—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000747	0.00559	CcSEcCtD
Amprenavir—Asthenia—Teniposide—lymphatic system cancer	0.000722	0.0054	CcSEcCtD
Amprenavir—Pruritus—Teniposide—lymphatic system cancer	0.000712	0.00532	CcSEcCtD
Amprenavir—Cardiac disorder—Vincristine—lymphatic system cancer	0.000706	0.00528	CcSEcCtD
Amprenavir—Mental disorder—Carmustine—lymphatic system cancer	0.000698	0.00522	CcSEcCtD
Amprenavir—Malnutrition—Carmustine—lymphatic system cancer	0.000693	0.00519	CcSEcCtD
Amprenavir—Diarrhoea—Teniposide—lymphatic system cancer	0.000688	0.00515	CcSEcCtD
Amprenavir—Myalgia—Bleomycin—lymphatic system cancer	0.000676	0.00506	CcSEcCtD
Amprenavir—Discomfort—Bleomycin—lymphatic system cancer	0.000668	0.005	CcSEcCtD
Amprenavir—Mental disorder—Vincristine—lymphatic system cancer	0.000666	0.00498	CcSEcCtD
Amprenavir—Tremor—Carmustine—lymphatic system cancer	0.00065	0.00486	CcSEcCtD
Amprenavir—Vomiting—Teniposide—lymphatic system cancer	0.00064	0.00479	CcSEcCtD
Amprenavir—Asthenia—Fludarabine—lymphatic system cancer	0.000634	0.00475	CcSEcCtD
Amprenavir—Rash—Teniposide—lymphatic system cancer	0.000634	0.00475	CcSEcCtD
Amprenavir—Dermatitis—Teniposide—lymphatic system cancer	0.000634	0.00474	CcSEcCtD
Amprenavir—Headache—Teniposide—lymphatic system cancer	0.00063	0.00472	CcSEcCtD
Amprenavir—Pruritus—Fludarabine—lymphatic system cancer	0.000626	0.00468	CcSEcCtD
Amprenavir—Anorexia—Bleomycin—lymphatic system cancer	0.000618	0.00462	CcSEcCtD
Amprenavir—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000613	0.00459	CcSEcCtD
Amprenavir—Diarrhoea—Fludarabine—lymphatic system cancer	0.000605	0.00453	CcSEcCtD
Amprenavir—Nausea—Teniposide—lymphatic system cancer	0.000598	0.00447	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000591	0.00442	CcSEcCtD
Amprenavir—Myalgia—Carmustine—lymphatic system cancer	0.00059	0.00442	CcSEcCtD
Amprenavir—Paraesthesia—Bleomycin—lymphatic system cancer	0.000582	0.00436	CcSEcCtD
Amprenavir—Decreased appetite—Bleomycin—lymphatic system cancer	0.000564	0.00422	CcSEcCtD
Amprenavir—Myalgia—Vincristine—lymphatic system cancer	0.000563	0.00422	CcSEcCtD
Amprenavir—Vomiting—Fludarabine—lymphatic system cancer	0.000562	0.00421	CcSEcCtD
Amprenavir—Rash—Fludarabine—lymphatic system cancer	0.000557	0.00417	CcSEcCtD
Amprenavir—Dermatitis—Fludarabine—lymphatic system cancer	0.000557	0.00417	CcSEcCtD
Amprenavir—Headache—Fludarabine—lymphatic system cancer	0.000554	0.00414	CcSEcCtD
Amprenavir—Myalgia—Mitoxantrone—lymphatic system cancer	0.000549	0.00411	CcSEcCtD
Amprenavir—Discomfort—Mitoxantrone—lymphatic system cancer	0.000542	0.00406	CcSEcCtD
Amprenavir—Anorexia—Carmustine—lymphatic system cancer	0.000539	0.00404	CcSEcCtD
Amprenavir—Nervous system disorder—Vincristine—lymphatic system cancer	0.00053	0.00396	CcSEcCtD
Amprenavir—Nausea—Fludarabine—lymphatic system cancer	0.000525	0.00393	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000516	0.00386	CcSEcCtD
Amprenavir—Anorexia—Vincristine—lymphatic system cancer	0.000515	0.00385	CcSEcCtD
Amprenavir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000511	0.00382	CcSEcCtD
Amprenavir—Paraesthesia—Carmustine—lymphatic system cancer	0.000508	0.0038	CcSEcCtD
Amprenavir—Anorexia—Mitoxantrone—lymphatic system cancer	0.000501	0.00375	CcSEcCtD
Amprenavir—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000492	0.00368	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000492	0.00368	CcSEcCtD
Amprenavir—Decreased appetite—Carmustine—lymphatic system cancer	0.000492	0.00368	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000489	0.00365	CcSEcCtD
Amprenavir—Paraesthesia—Vincristine—lymphatic system cancer	0.000485	0.00363	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000479	0.00359	CcSEcCtD
Amprenavir—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000472	0.00353	CcSEcCtD
Amprenavir—Decreased appetite—Vincristine—lymphatic system cancer	0.00047	0.00351	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000466	0.00349	CcSEcCtD
Amprenavir—Fatigue—Vincristine—lymphatic system cancer	0.000466	0.00348	CcSEcCtD
Amprenavir—Asthenia—Bleomycin—lymphatic system cancer	0.000465	0.00348	CcSEcCtD
Amprenavir—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000463	0.00346	CcSEcCtD
Amprenavir—Pruritus—Bleomycin—lymphatic system cancer	0.000459	0.00343	CcSEcCtD
Amprenavir—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000457	0.00342	CcSEcCtD
Amprenavir—Fatigue—Mitoxantrone—lymphatic system cancer	0.000454	0.00339	CcSEcCtD
Amprenavir—Abdominal pain—Carmustine—lymphatic system cancer	0.000447	0.00335	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000442	0.00331	CcSEcCtD
Amprenavir—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000442	0.0033	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—lymphatic system cancer	0.000431	0.00322	CcSEcCtD
Amprenavir—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00043	0.00322	CcSEcCtD
Amprenavir—Abdominal pain—Vincristine—lymphatic system cancer	0.000427	0.00319	CcSEcCtD
Amprenavir—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000416	0.00311	CcSEcCtD
Amprenavir—Vomiting—Bleomycin—lymphatic system cancer	0.000412	0.00308	CcSEcCtD
Amprenavir—Depression—Methotrexate—lymphatic system cancer	0.00041	0.00307	CcSEcCtD
Amprenavir—Rash—Bleomycin—lymphatic system cancer	0.000409	0.00306	CcSEcCtD
Amprenavir—Dermatitis—Bleomycin—lymphatic system cancer	0.000408	0.00306	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000407	0.00305	CcSEcCtD
Amprenavir—Asthenia—Carmustine—lymphatic system cancer	0.000406	0.00304	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000389	0.00291	CcSEcCtD
Amprenavir—Asthenia—Vincristine—lymphatic system cancer	0.000388	0.0029	CcSEcCtD
Amprenavir—Diarrhoea—Carmustine—lymphatic system cancer	0.000387	0.0029	CcSEcCtD
Amprenavir—Nausea—Bleomycin—lymphatic system cancer	0.000385	0.00288	CcSEcCtD
Amprenavir—Asthenia—Mitoxantrone—lymphatic system cancer	0.000377	0.00282	CcSEcCtD
Amprenavir—Diarrhoea—Vincristine—lymphatic system cancer	0.00037	0.00277	CcSEcCtD
Amprenavir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00036	0.00269	CcSEcCtD
Amprenavir—Vomiting—Carmustine—lymphatic system cancer	0.00036	0.00269	CcSEcCtD
Amprenavir—Rash—Carmustine—lymphatic system cancer	0.000357	0.00267	CcSEcCtD
Amprenavir—Dermatitis—Carmustine—lymphatic system cancer	0.000356	0.00267	CcSEcCtD
Amprenavir—Headache—Carmustine—lymphatic system cancer	0.000354	0.00265	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000349	0.00261	CcSEcCtD
Amprenavir—Vomiting—Vincristine—lymphatic system cancer	0.000343	0.00257	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000342	0.00256	CcSEcCtD
Amprenavir—Rash—Vincristine—lymphatic system cancer	0.000341	0.00255	CcSEcCtD
Amprenavir—Dermatitis—Vincristine—lymphatic system cancer	0.00034	0.00255	CcSEcCtD
Amprenavir—Headache—Vincristine—lymphatic system cancer	0.000338	0.00253	CcSEcCtD
Amprenavir—Nausea—Carmustine—lymphatic system cancer	0.000336	0.00251	CcSEcCtD
Amprenavir—Vomiting—Mitoxantrone—lymphatic system cancer	0.000334	0.0025	CcSEcCtD
Amprenavir—Rash—Mitoxantrone—lymphatic system cancer	0.000332	0.00248	CcSEcCtD
Amprenavir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000331	0.00248	CcSEcCtD
Amprenavir—Headache—Mitoxantrone—lymphatic system cancer	0.00033	0.00247	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—lymphatic system cancer	0.000323	0.00242	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—lymphatic system cancer	0.000321	0.0024	CcSEcCtD
Amprenavir—Nausea—Vincristine—lymphatic system cancer	0.000321	0.0024	CcSEcCtD
Amprenavir—Nausea—Mitoxantrone—lymphatic system cancer	0.000312	0.00234	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—lymphatic system cancer	0.000273	0.00205	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000272	0.00203	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—lymphatic system cancer	0.00027	0.00202	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000257	0.00192	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—lymphatic system cancer	0.000255	0.0019	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—lymphatic system cancer	0.00025	0.00187	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000239	0.00179	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—lymphatic system cancer	0.000235	0.00176	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—lymphatic system cancer	0.000228	0.0017	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000226	0.00169	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—lymphatic system cancer	0.000226	0.00169	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000214	0.0016	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—lymphatic system cancer	0.000207	0.00155	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—lymphatic system cancer	0.000188	0.00141	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—lymphatic system cancer	0.000185	0.00139	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—lymphatic system cancer	0.000179	0.00134	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—lymphatic system cancer	0.000167	0.00125	CcSEcCtD
Amprenavir—Rash—Methotrexate—lymphatic system cancer	0.000165	0.00124	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—lymphatic system cancer	0.000165	0.00124	CcSEcCtD
Amprenavir—Headache—Methotrexate—lymphatic system cancer	0.000164	0.00123	CcSEcCtD
Amprenavir—Nausea—Methotrexate—lymphatic system cancer	0.000156	0.00116	CcSEcCtD
